Thermo Fisher Takes Deep Dive into Cell and Gene Therapy with Viral Vector Business Buy

Thermo Fisher Takes Deep Dive into Cell and Gene Therapy with Viral Vector Business Buy

Source: 
BioSpace
snippet: 

Thermo Fisher Scientific announced the completion of Henogen SA, Groupe Novasep SAS’s viral vector manufacturing business in Belgium. The deal was for €725 million in cash.